Mitofusin 2 inhibits mitochondrial antiviral signaling

Kai Yasukawa1, Hiroyuki Oshiumi, Makoto Takeda

  • 1Department of Biology, Kyushu University, Hakozaki, Higashi-ku, Fukuoka, Japan.

Science Signaling
|August 20, 2009
PubMed

Insights

Mitofusin 2 (Mfn2) inhibits antiviral immunity by interacting with MAVS, suppressing key signaling pathways. Loss of Mfn2 enhances interferon production and reduces viral replication, revealing Mfn2

Area of Science:

  • Immunology
  • Cell Biology
  • Virology

Background:

  • The innate immune system protects against viral infections through complex signaling pathways.
  • Mitochondrial antiviral signaling (MAVS) is crucial for initiating antiviral responses, including type I interferon (IFN) production.
  • Mitofusin 2 (Mfn2) is primarily known for its role in regulating mitochondrial fusion.

Purpose of the Study:

  • To investigate the role of mitofusin 2 (Mfn2) in modulating antiviral immunity.
  • To determine the interaction between Mfn2 and MAVS in the context of viral infection.
  • To elucidate the functional consequences of Mfn2 on innate antiviral signaling.

Main Methods:

  • Overexpression and knockdown of Mfn2 in cellular models.
  • Analysis of RIG-I and MDA-5 signaling pathways.
  • Measurement of IRF-3 and NF-kappaB activation.
  • Assessment of IFN-beta production and viral replication.
  • Structure-function analysis of Mfn2-MAVS interaction.

Main Results:

  • Mfn2 overexpression inhibited RIG-I and MDA-5 signaling, as well as MAVS-mediated activation of IRF-3 and NF-kappaB.
  • Loss of endogenous Mfn2 enhanced virus-induced IFN-beta production.
  • Reduced viral replication was observed in cells lacking Mfn2.
  • Mfn2 directly interacts with the carboxyl-terminal region of MAVS.

Conclusions:

  • Mfn2 acts as a negative regulator of antiviral signaling, distinct from its role in mitochondrial fusion.
  • The interaction between Mfn2 and MAVS provides a novel mechanism for controlling innate antiviral responses.
  • Targeting the Mfn2-MAVS interaction could offer therapeutic strategies against viral infections.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...